Pediatrix Medical Group, Inc. (MD)

NYSE: MD · Real-Time Price · USD

26.94

-0.09 (-0.33%)

At close: Sep 8, 2026, 4:00 PM EDT

26.96

+0.02 (0.07%)

After-hours: Sep 8, 2026, 4:00 PM EDT

Pediatrix Medical Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	288.88	375.24	229.94	73.26	9.82	387.39
Short-Term Investments	115.32	124.48	118.57	104.49	93.24	99.72
Cash & Short-Term Investments	404.2	499.72	348.51	177.74	103.06	487.11
Cash Growth	16.04%	43.39%	96.07%	72.46%	-78.84%	-60.36%
Accounts Receivable	227.6	229.67	259.99	272.31	296.79	301.78
Other Receivables	11.4	12.64	12.61	7.57	-	14.25
Receivables	239.01	242.31	272.6	279.88	296.79	316.02
Prepaid Expenses	9.58	12.61	13.41	13.53	14.88	18.54
Other Current Assets	7.36	8.88	5.09	12.31	13.26	18.9
Total Current Assets	660.14	763.51	639.61	483.45	427.99	840.56
Property, Plant & Equipment	73.89	73.51	78.44	145.93	140.21	135.62
Goodwill	1,268	1,261	1,243	1,384	1,532	1,505
Other Intangible Assets	14.51	16.86	11.6	21.24	18.49	21.57
Long-Term Deferred Tax Assets	56.11	73.92	103.86	102.85	105.93	88.34
Other Long-Term Assets	57.43	58.16	76.6	82.17	123.18	131.03
Total Assets	2,130	2,247	2,153	2,220	2,348	2,723

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	27.85	37.22	46.43	34.59	31.86	36.65
Accrued Expenses	273.99	382.31	352.26	316.21	342.37	357.47
Current Portion of Long-Term Debt	186.18	25	18.75	12.5	12.5	-
Current Portion of Leases	12.24	13.4	14.5	23.49	23.99	22.17
Current Income Taxes Payable	1.32	0.98	2.17	2.16	16.27	11.07
Total Current Liabilities	501.58	458.91	434.11	388.95	426.98	427.37
Long-Term Debt	398.06	568.95	593.57	611.59	627.65	990.57
Long-Term Leases	23.48	27.27	35.49	54.07	52.94	53.08
Long-Term Deferred Tax Liabilities	58.71	57.02	34.25	34.31	33.64	41.41
Other Long-Term Liabilities	267.54	268.69	290.34	281.84	315.04	313.43
Total Liabilities	1,249	1,381	1,388	1,371	1,456	1,826

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.81	0.83	0.86	0.84	0.83	0.86
Additional Paid-In Capital	894.29	947.57	1,014	999.91	983.6	1,050
Retained Earnings	-13.74	-83.15	-248.54	-149.47	-89.06	-155.39
Comprehensive Income & Other	-0.39	0.61	-1.07	-2.21	-3.74	1.32
Total Common Equity	880.98	865.85	764.94	849.06	891.63	896.49
Minority Interest	-	-	-	-	-	0.21
Shareholders' Equity	880.98	865.85	764.94	849.06	891.63	896.69
Total Liabilities & Equity	2,130	2,247	2,153	2,220	2,348	2,723

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	619.96	634.62	662.31	701.65	717.08	1,066
Net Cash (Debt)	-215.76	-134.89	-313.81	-523.91	-614.02	-578.72
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-2.58	-1.58	-3.77	-6.37	-7.30	-6.74
Filing Date Shares Outstanding	79.32	81.07	84.13	82.77	81.84	85.33
Total Common Shares Outstanding	79.29	81.04	84.17	82.66	81.75	85.28
Working Capital	158.56	304.6	205.5	94.51	1.01	413.2
Book Value Per Share	11.11	10.68	9.09	10.27	10.91	10.51
Tangible Book Value	-401.79	-411.74	-489.26	-556.35	-658.95	-630.51
Tangible Book Value Per Share	-5.07	-5.08	-5.81	-6.73	-8.06	-7.39
Land	-	2.03	2.03	2.03	2.03	2.03
Buildings	-	8.29	8.29	8.29	8.29	8.29
Machinery	-	161.2	155.36	208.04	235.19	224.52

SEC Filings: 10-K · 10-Q